Related Experiment Videos
Recurrent peritoneal mesothelioma with long-delayed recurrence.
1Saint Vincent Hospital-Worcester Medical Center, Department of Medicine, Worcester, Massachusetts 01604, USA.
Journal of Clinical Gastroenterology
|August 14, 2001
Summary
This case study highlights a rare instance of peritoneal mesothelioma with a 19-year survival and a significantly delayed recurrence. Aggressive chemotherapy may improve survival outcomes for this uncommon cancer.
Area of Science:
- Oncology
- Gastroenterology
Background:
- Peritoneal mesothelioma is a rare cancer with a poor prognosis and unclear etiology.
- It often presents atypically, with limited reports of long-term survival.
Observation:
- A unique case of peritoneal mesothelioma with a 19-year disease duration is presented.
- Recurrence was observed after a long delay, confirmed by biopsy comparison.
- The patient experienced paraneoplastic manifestations, including hepatopathy and wasting syndrome.
Findings:
- Aggressive and intensive chemotherapy demonstrated potential for prolonging survival in this peritoneal mesothelioma case.
- This report details an exceptionally long-delayed recurrence of peritoneal mesothelioma, previously undocumented.
Implications:
- This case suggests that aggressive management, including chemotherapy, may improve survival in peritoneal mesothelioma.
- Further research into the long-term behavior and treatment of peritoneal mesothelioma is warranted.